Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.110
+0.110 (2.75%)
May 2, 2025, 10:51 AM EDT - Market open

Radiopharm Theranostics Statistics

Total Valuation

RADX has a market cap or net worth of $34.29 million. The enterprise value is $10.25 million.

Market Cap 34.29M
Enterprise Value 10.25M

Important Dates

The last earnings date was Wednesday, February 26, 2025.

Earnings Date Feb 26, 2025
Ex-Dividend Date n/a

Share Statistics

RADX has 2.20 billion shares outstanding. The number of shares has increased by 243.78% in one year.

Current Share Class n/a
Shares Outstanding 2.20B
Shares Change (YoY) +243.78%
Shares Change (QoQ) +327.30%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 1.54B

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 167.58
Forward PS n/a
PB Ratio 1.07
P/TBV Ratio 10.65
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 50.09
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.37

Current Ratio 3.37
Quick Ratio 3.25
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -59.53

Financial Efficiency

Return on equity (ROE) is -112.21% and return on invested capital (ROIC) is -59.05%.

Return on Equity (ROE) -112.21%
Return on Assets (ROA) -28.95%
Return on Invested Capital (ROIC) -59.05%
Return on Capital Employed (ROCE) -45.48%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

In the past 12 months, RADX has paid $102,799 in taxes.

Income Tax 102,799
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) 0.85
52-Week Price Change n/a
50-Day Moving Average 5.01
200-Day Moving Average n/a
Relative Strength Index (RSI) 38.86
Average Volume (20 Days) 31,049

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RADX had revenue of $204,609 and -$26.61 million in losses. Loss per share was -$0.02.

Revenue 204,609
Gross Profit -13.23M
Operating Income -22.32M
Pretax Income n/a
Net Income -26.61M
EBITDA -20.42M
EBIT -22.32M
Loss Per Share -$0.02
Full Income Statement

Balance Sheet

The company has $22.55 million in cash and n/a in debt, giving a net cash position of $22.55 million or $0.01 per share.

Cash & Cash Equivalents 22.55M
Total Debt n/a
Net Cash 22.55M
Net Cash Per Share $0.01
Equity (Book Value) 32.18M
Book Value Per Share 0.01
Working Capital 19.31M
Full Balance Sheet

Cash Flow

Operating Cash Flow -20.68M
Capital Expenditures n/a
Free Cash Flow -21.34M
FCF Per Share -$0.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -10,908.65%
Pretax Margin -12,905.07%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RADX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -243.78%
Shareholder Yield -243.78%
Earnings Yield -77.61%
FCF Yield -62.24%

Analyst Forecast

The average price target for RADX is $13.50, which is 228.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target $13.50
Price Target Difference 228.47%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) 163.67%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RADX has an Altman Z-Score of -2.23 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -2.23
Piotroski F-Score 2